Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
Abstract Fragile X syndrome (FXS) is the leading known cause of inherited intellectual disability and autism spectrum disorder. It is caused by a mutation of the fragile X mental retardation 1 (FMR1) gene, resulting in a […]